Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Abb Vie Inc. Call Options Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$88.7 Billion
Q1 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $384 Million - $442 Million	2,656,500 New	2,656,500 $423 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.42 Million - $1.58 Million	16,000 New	16,000 $0

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

Vanguard Group Inc Valley Forge, PA

170M
Shares

$28.3 Billion
0.62% of portfolio
Black Rock Inc. New York, NY

143M
Shares

$23.7 Billion
0.61% of portfolio
State Street Corp Boston, MA

78M
Shares

$12.9 Billion
0.64% of portfolio
Jpmorgan Chase & CO New York, NY

51.3M
Shares

$8.51 Billion
0.85% of portfolio
Capital International Investors Los Angeles, CA

48.1M
Shares

$7.98 Billion
1.81% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account